Literature DB >> 11446654

The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.

H Karch1.   

Abstract

Enterohemorrhagic Escherichia coli (EHEC) are the most common cause of postdiarrheal hemolytic-uremic syndrome (HUS). The most important EHEC serotype implicated worldwide is O157:H7. However, several so-called non-O157 EHEC serotypes have emerged. After a mean incubation period of 3 days, patients develop watery diarrhea accompanied by cramping abdominal pain. During the next days, in most patients watery diarrhea changes to bloody diarrhea. One week after the onset of diarrhea, in about 15% of infected patients under 10 years of age EHEC infection results in a systemic complication, HUS. Shiga toxins (Stxs) are considered the major virulence factors of EHEC involved in the pathogenesis of HUS. It is generally believed that after intestinal infection with EHEC, Stxs cross the intestinal barrier and bind to endothelial cells. At this point they presumably injure the host cell by inhibition of protein synthesis, stimulation of prothrombotic messages, or induction of apoptosis. The B subunit of Stx binds to the membrane receptor globotriaosylceramide (Gb3). Gb3 facilitates the endocytosis and intracellular trafficking of the toxin. The Stx A subunit hydrolyzes a specific adenine residue of the 60S ribosomal subunit of mammalian cells. As a consequence, Stx shuts down the protein machinery of the susceptible cell. The HUS is the net effect of a variety of interacting factors, including background risk of acquisition, host factors (such as age), virulence characteristics of the infecting EHEC strain, and exogenous factors. All known EHEC virulence determinants are located on mobile genetic elements, and this has an important impact on the evolution of these pathogens. The evolution of EHEC has a dynamic component that includes different genetic mechanisms. The recent progress in understanding the pathogenesis and epidemiology of EHEC infections forms a basis for the development of future strategies to prevent EHEC infections in humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11446654     DOI: 10.1055/s-2001-15250

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  14 in total

1.  Seasonal variation of HUS occurrence and VTEC infection in children with acute diarrhoea from Argentina.

Authors:  M A Rivero; J A Passucci; E M Rodríguez; A E Parma
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-22       Impact factor: 3.267

Review 2.  Enterobacteria and host resistance to infection.

Authors:  Eugene Kang; Alanna Crouse; Lucie Chevallier; Stéphanie M Pontier; Ashwag Alzahrani; Navoun Silué; François-Xavier Campbell-Valois; Xavier Montagutelli; Samantha Gruenheid; Danielle Malo
Journal:  Mamm Genome       Date:  2018-05-21       Impact factor: 2.957

3.  Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles.

Authors:  Marjut Eklund; Kirsikka Leino; Anja Siitonen
Journal:  J Clin Microbiol       Date:  2002-12       Impact factor: 5.948

4.  Biochemical, pathological and oncological relevance of Gb3Cer receptor.

Authors:  D Đevenica; V Čikeš Čulić; A Vuica; A Markotić
Journal:  Med Oncol       Date:  2010-11-11       Impact factor: 3.064

5.  Shiga toxin-2 results in renal tubular injury but not thrombotic microangiopathy in heterozygous factor H-deficient mice.

Authors:  D Paixão-Cavalcante; M Botto; H T Cook; M C Pickering
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

6.  Host susceptibility to the attaching and effacing bacterial pathogen Citrobacter rodentium.

Authors:  Bruce A Vallance; Wanyin Deng; Kevan Jacobson; B Brett Finlay
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

7.  Fitness of Enterohemorrhagic Escherichia coli (EHEC)/Enteroaggregative E. coli O104:H4 in Comparison to That of EHEC O157: Survival Studies in Food and In Vitro.

Authors:  Christina Böhnlein; Jan Kabisch; Diana Meske; Charles M A P Franz; Rohtraud Pichner
Journal:  Appl Environ Microbiol       Date:  2016-10-14       Impact factor: 4.792

8.  Molecular analysis of subtilase cytotoxin genes of food-borne Shiga toxin-producing Escherichia coli reveals a new allelic subAB variant.

Authors:  Joschua Funk; Helen Stoeber; Elisabeth Hauser; Herbert Schmidt
Journal:  BMC Microbiol       Date:  2013-10-15       Impact factor: 3.605

9.  Enterohemorrhagic Escherichia coli senses low biotin status in the large intestine for colonization and infection.

Authors:  Bin Yang; Lu Feng; Fang Wang; Lei Wang
Journal:  Nat Commun       Date:  2015-03-20       Impact factor: 14.919

10.  EspP, an Extracellular Serine Protease from Enterohemorrhagic E. coli, Reduces Coagulation Factor Activities, Reduces Clot Strength, and Promotes Clot Lysis.

Authors:  Kevin H M Kuo; Shekeb Khan; Margaret L Rand; Hira S Mian; Elena Brnjac; Linda E Sandercock; Indira Akula; Jean-Philippe Julien; Emil F Pai; Alden E Chesney
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.